MedPath

To study the effects of Lamotrigine and Pregabalin in patients with pain after stroke and treatment of drug resistant cases either by repetitive transcranial magnetic stimulation (rTMS) or by placebo.

Phase 4
Conditions
Health Condition 1: null- Diagnosed case of post-stroke pain
Registration Number
CTRI/2012/02/002438
Lead Sponsor
Sanjay Gandhi Postgraduate Institute of Medical Sciences SGPGIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1.Diagnosis of post-stroke pain

1.age of patient between 18-70 years.

3.Base line Pain at VAS >= 50mm on 100mm scale.

4.Informed signed consent

Exclusion Criteria

1.Peripheral neuropathy

2.Pericapsulitis

3.Dementia

4.Malignant disease

5.Recent MI

6.Liver/renal failure

7.Known allergy to lamotrigine or pregabalin

8.Pregnant or lactating

9.The patients with cardiac pacing or any metallic implantation will be excluded from rTMS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Efficacy of Lamotrigine and Pregabalin in the Treatment of central post-stroke pain at VAS scale. <br/ ><br>2.The efficacy of rTMS (repetitive magnetic stimulation) will be evaluated in the refractory patients. <br/ ><br>Timepoint: Completion of 12 weeks in each arm
Secondary Outcome Measures
NameTimeMethod
Side effect of each drugs <br/ ><br>Timepoint: 12 weeks
© Copyright 2025. All Rights Reserved by MedPath